CATEGORY TITLE
OSHA compliance and awareness in bioscience and laboratory environments
Bioscience and laboratory work depends on precision, but safe practice also depends on awareness. Researchers, technicians, production teams, and support staff may work near chemicals, biological materials, specialist equipment, or controlled processes. OSHA safety training gives laboratory and bioscience...
Well-characterised biospecimens assist development of cancer immunotherapies
Amsbio report how its biospecimens were used in a large-scale immuno-oncology study analysing Fibroblast Activation protein (FAP) expression across 23 tumour types, contributing to new insights into biomarker development for cancer immunotherapies.
Scientists at Roche Pharma Research used both immunohistochemistry...
Validated monospecific recombinant and monoclonal antibodies
Amsbio has expanded its diverse range of recombinant and monoclonal antibodies to include over 10,000 new validated monospecific products in 15,000 formulations to support research in cancer, immunology, neuroscience, and signal transduction.
Every antibody in the new catalogue has been...
Why Grangemouth is shaping the next phase of Scotland’s bioeconomy
Scotland’s largest industrial cluster is entering a new phase that will help redefine its place on the world stage, says Mark Bustard, CEO at the Industrial Biotechnology Innovation Centre (IBioIC).
Scotland’s bioeconomy is often discussed as a future opportunity, yet...
Glasgow health tech firm secures £2m grant to transform medicine inhalation
Nebu~Flow® has been awarded a £2m Scottish Enterprise grant to accelerate development and patient access to its patented nebuliser technology in the UK and globally.
The technology is designed to improve how people receive inhaled medicines, paving the way for...
Innovation network brings bioprinted medicine closer to reality
Millions of people worldwide are losing their sight waiting for corneal transplants. To end this dependence on donors, researchers are working on 3D-printing replacement corneas from stem cells.
A new multimillion-euro international research network has been set up to accelerate...
Diabetes: a protective gel for a future without insulin injections
By developing an innovative gel, UNIGE and HUG researchers have achieved a major breakthrough toward a bioartificial pancreas.
Researchers from the University of Geneva (UNIGE) and Geneva University Hospitals (HUG) have reached a significant advance in the fight against type...
Living ‘tumour on a chip’ could give best insight into aggressive brain cancer
Scientists are creating a glioblastoma ‘tumour on a chip’– a tiny living system capable of mimicking the key features of the human brain and providing a deeper understanding of how the aggressive brain cancer works.
It is hoped that the...
Growing sustainable rubber from dandelions
A Norwich-based biotech firm is developing sustainable natural rubber from specially engineered dandelions.
QuberTech recently raised £3.4 million in combined grant funding and equity investment to accelerate development of its engineering biology platform and scale commercial operations.
The funding backs QuberTech’s...
Implantable tech could cast new light on bladder cancer treatment
A new implantable device which aims to maximise the effectiveness of light-sensitive drugs could improve future outcomes for bladder cancer patients.
Engineers and cancer scientists from the University of Glasgow have developed the device, which uses wirelessly powered micro-LEDs to...
Manchester team powers next-gen enzyme engineering
A University of Manchester techbio spin-out has secured £5 million to deploy quantum physics, AI modelling, and highly automated labs to power next-gen enzyme engineering.
Imperagen has raised a total of £8.5m to accelerate R&D, expand wet lab capabilities, and...
Funding will enable cutting-edge heart research
Researchers at UK universities are launching a major new research project which aims to create the world’s most detailed 3D images of the mechanical forces at work inside a living, beating heart.
The £4 million award from the Wellcome Trust...
World first: genome loaded onto quantum computer
Scientists have achieved a world first by loading a complete genome onto a quantum computer – a major step towards using quantum computing to tackle some of biology’s most complex bioinformatic challenges.
The breakthrough comes from a collaboration between...
Delivering versatility without complexity in medical technology
In laboratory instruments, linear motion is where precision meets practicality. Whether positioning a pipette, advancing a fluid, or moving a sample through a preparation workflow, designers need motion that is accurate, repeatable, and dependable over long duty cycles. At...
Why high performance cultures break down under pressure in bioscience organisations
High performance in bioscience organisations rarely breaks down because people aren’t capable. It breaks down when scientific, regulatory and commercial pressure increases, but the systems supporting performance don’t evolve with it. What looks like a talent or execution issue...
A growing bioscience cluster – built for innovation, scale & impact
As the UK’s life sciences sector continues to grow, businesses are increasingly looking for environments that offer more than just laboratory space. Access to talent, specialist infrastructure, research expertise and opportunities for collaboration are becoming critical factors in supporting...
Longitude Prize on ALS awards £2 million to 20 international teams
The Longitude Prize on ALS is awarding £2 million to 20 of the world’s most promising multidisciplinary teams of innovators using AI to find new drug targets for ALS (amyotrophic lateral sclerosis) – the most common form of MND...
Redefining the future of surgery
Nerve repair demands complex microsurgical suturing skills. Maria Pereira, co-founder of TISSIUM, explains how biomorphic materials are changing the landscape of surgical repair.
For decades, we have tried to repair the human body with materials and solutions that don’t heal...
Injectable gel could help repair damaged swallowing muscles
Biomaterial increases stem cell survival fivefold in preclinical tests, paving the way for advances in regenerative treatments.
A new injectable gel developed by researchers at McGill University and Kyoto University could enable stem cell-based treatments for swallowing disorders.
While stem...
Miniature biological factories created inside living cells
A six-protein team - successfully operating inside living cells as a single integrated system - points to a future where medicine could be made directly at the site of disease.
Scientists have engineered small particles to transport a team of...
Coral surface behaviour offers insights into physics of infertility and ovarian cancer
A new study could hold the key to understanding the causes of long-term health problems, such as infertility and ovarian cancer.
The study, published in Physics Review X Life, used a combination of high-resolution imaging, flow measurements, and mathematical modelling to examine...
Biochemical Society Research Support Award winners announced
Two members of Aston Institute for Membrane Excellence (AIME), Helen Elwood and Paul Knobbs, have won the Biochemical Society 2027 Research Support Award.
The award is presented to an individual or team demonstrating an outstanding contribution and impact to a...
£439,000 Leverhulme Trust grant to research membrane protein folding
Aston Institute for Membrane Excellence (AIME) has won a £438,674 Research Project Grant from the Leverhulme Trust to carry out fundamental research into how membrane proteins fold correctly.
The proteins that make up the body are made at membranes in...
Study of millions of cells unveils new understanding of genetic risk
Scientists have created the most detailed cell map to date showing how genetic variation influences inflammatory bowel disease (IBD), revealing the specific cells and genes that drive the disease.
Published in Nature, the research carried out at the Wellcome...
Potential new route for antimalarial drug design
A significant advance has been made in the fight against malaria with a promising new potential target for drug discovery.
The findings – made by researchers from the Universities of Bath and Leeds – provide a powerful new framework...
UK biotech launches world-first lab-grown human muscle platform to transform drug testing
A Loughborough University spin-out has developed advanced human muscle models designed to more accurately replicate how medicines behave in the human body. The aim is to accelerate drug development and reduce reliance on animal testing.
Myomaker Bio is set to...
First best-practice framework for ethical social media use in drug development
The Pistoia Alliance calls for funding and expertise for the next phase of its social media project, marking its first direct engagement with oncology, rare disease and cardiology patients.
The Alliance, a global, not-for-profit alliance advancing collaboration in life sciences...
Scientists develop cheaper, more sustainable way to manufacture HIV drug
With financial support from the Gates Foundation, researchers at the Manchester Institute of Biotechnology (MIB) have used engineering biology – an emerging technology that uses nature’s own processes to manufacture everyday chemicals and materials – to dramatically simplify how...
Beyond biopsies: new methods of collecting data for dermatology research
Théo Boyer, project manager at Indero, explores how novel methodologies could influence the collection of biological data in future clinical research.
Dermatology trials frequently rely on blood draws and skin biopsies to evaluate inflammatory pathways, pharmacodynamic activity and drug exposure.
While...
Middle East disruption is affecting global clinical trials
Analysis of 65,000+ trials and 350,000+ sites show thousands of studies affected, with Phase III trials most exposed.
Analysis of 65,061 globally recruiting clinical trials across 186 countries has found that 4,361 studies - equivalent to 6.7% of all active...
